Basic Information
ALK is a global research-based pharmaceutical company focused on the prevention, diagnosis, and treatment of allergies. Since 1923, ALK has been committed to improving the quality of life for allergy sufferers by developing medications targeting allergies. ALK is a global leader in allergen immunotherapy.
ALK-Abello A/S
Denmark
more than 500 people
January 01, 1923
reception@alk-abello.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios